HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rachid Baz Selected Research
Rachid Baz Research Topics
Disease
49
Multiple Myeloma
12/2023 - 08/2004
13
Neoplasms (Cancer)
12/2023 - 02/2007
4
Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 12/2011
3
Plasma Cell Leukemia
10/2023 - 12/2011
3
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2017 - 10/2007
2
Amyloidosis
01/2022 - 09/2015
2
Disease Progression
01/2020 - 03/2016
2
Neutropenia
01/2020 - 01/2017
2
Hyponatremia
01/2020 - 01/2017
2
Thrombocytopenia (Thrombopenia)
01/2020 - 01/2017
2
Fatigue
01/2020 - 01/2017
2
Anemia
01/2017 - 08/2004
1
Central Nervous System Diseases (CNS Diseases)
01/2022
1
Progressive Multifocal Leukoencephalopathy
01/2022
1
Immunoglobulin Light-chain Amyloidosis
01/2022
1
Leukoencephalopathies
01/2022
1
Weight Loss (Weight Reduction)
01/2020
1
Nausea
01/2020
1
Vomiting
01/2020
1
Diarrhea
01/2020
1
Plasma Cell Neoplasms
04/2019
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018
1
Leukemia
01/2018
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2018
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1
Pneumonia (Pneumonitis)
01/2017
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2017
1
Leukopenia
01/2017
1
Acute Kidney Injury (Acute Renal Failure)
03/2016
1
Sepsis (Septicemia)
03/2016
Drug/Important Bio-Agent (IBA)
16
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022 - 12/2005
14
Bortezomib (Velcade)
FDA Link
01/2022 - 12/2011
12
Lenalidomide (CC 5013)
FDA Link
01/2022 - 02/2007
6
selinexor
IBA
01/2020 - 01/2016
5
Melphalan (Alkeran)
FDA Link
Generic
01/2017 - 12/2007
4
Monoclonal Antibodies
IBA
01/2022 - 01/2017
4
Exportin 1 Protein
IBA
01/2020 - 01/2016
4
Proteasome Inhibitors
IBA
01/2020 - 08/2014
4
liposomal doxorubicin (Doxil)
FDA Link
01/2016 - 07/2006
4
Thalidomide (Thalomid)
FDA Link
08/2014 - 12/2005
3
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
12/2023 - 09/2023
3
B-Cell Maturation Antigen
IBA
10/2023 - 01/2020
3
Proteins (Proteins, Gene)
FDA Link
01/2020 - 08/2014
3
ixazomib
IBA
01/2018 - 08/2014
3
pomalidomide
IBA
12/2016 - 03/2013
3
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2016 - 12/2005
3
Vincristine (Oncovin)
FDA Link
Generic
04/2014 - 12/2005
2
idecabtagene vicleucel
IBA
10/2023 - 10/2023
2
Chimeric Antigen Receptors
IBA
10/2023 - 09/2023
2
daratumumab
IBA
01/2022 - 11/2021
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 11/2015
2
venetoclax
IBA
11/2021 - 01/2017
2
Histone Deacetylase Inhibitors
IBA
01/2018 - 07/2017
2
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
01/2018 - 01/2017
2
carfilzomib
IBA
08/2014 - 08/2014
2
Anthracyclines
IBA
04/2014 - 12/2005
2
Antineoplastic Agents (Antineoplastics)
IBA
02/2007 - 08/2006
2
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
08/2006 - 12/2005
1
Albumins
IBA
12/2023
1
Survivin
IBA
11/2023
1
Vaccines
IBA
11/2023
1
Ferritins (Ferritin)
IBA
10/2023
1
Tumor Biomarkers (Tumor Markers)
IBA
01/2022
1
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
01/2022
1
Eltanexor
IBA
01/2022
1
Serotonin 5-HT3 Receptor Antagonists
IBA
01/2020
1
Neurokinin-1 Receptor Antagonists
IBA
01/2020
1
belantamab mafodotin
IBA
01/2020
1
Olanzapine (Zyprexa)
FDA Link
01/2020
1
bismuth subsalicylate (Pepto-bismol)
FDA Link
Generic
01/2020
1
Loperamide (Imodium)
FDA Link
Generic
01/2020
1
Thrombopoietin Receptors
IBA
01/2020
1
Megestrol
IBA
01/2020
1
ulocuplumab
IBA
01/2020
1
Methylphenidate (Ritalin)
FDA Link
Generic
01/2020
1
Immunomodulating Agents
IBA
01/2020
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
01/2020
1
Sodium
IBA
01/2020
1
Immunoconjugates (Immunoconjugate)
IBA
01/2020
1
Cannabinoids
IBA
01/2020
1
plerixafor
FDA Link
11/2019
1
Immunoglobulins (Immunoglobulin)
IBA
04/2019
1
Vorinostat
FDA Link
01/2018
1
Glucocorticoid Receptors (Glucocorticoid Receptor)
IBA
01/2018
1
Oncogene Proteins (Oncogene Protein)
IBA
01/2018
1
isatuximab
IBA
01/2017
1
ricolinostat
IBA
01/2017
1
AZD 6244
IBA
03/2016
1
1-dodecylpyridoxal (PLD)
IBA
01/2016
1
Topoisomerase II Inhibitors
IBA
01/2016
1
marizomib
IBA
08/2014
Therapy/Procedure
28
Therapeutics
12/2023 - 01/2006
4
Drug Therapy (Chemotherapy)
01/2017 - 12/2005
2
Remission Induction
03/2008 - 10/2007
1
Immunotherapy
05/2024
1
Radiotherapy
08/2020
1
Intravenous Infusions
01/2020
1
Platelet Transfusion (Blood Platelet Transfusions)
01/2020
1
Precision Medicine
04/2019
1
Aftercare (After-Treatment)
01/2017